摘要
目的分析予以高危、超大前列腺增生患者经尿道前列腺等离子剜除术联合耻骨上小切口治疗的临床效果。方法选择2018年1月—2021年12月新沂市中医院收治的高危、超大前列腺增生患者42例为研究对象,采取随机数表法分为两组,其中予以行经尿道前列腺电切术治疗的17例纳入对照组,经尿道前列腺等离子剜除术联合耻骨上小切口治疗的25例纳入观察组,对比两组患者临床效果。结果观察组术中出血量(52.19±6.25)mL,少于对照组的(65.76±8.45)mL;且手术、冲洗膀胱时间为(62.20±10.45)、(5.20±1.10)min,短于对照组的(75.52±9.48)、(7.70±1.54)min;术中取出组织重量为(97.57±8.25)g,大于对照组的(86.26±8.32)g,差异有统计学意义(t=5.986、4.206、6.145、4.339,P<0.05)。观察组RUV指标、IPSS评分为(43.20±7.08)mL、(42.28±6.78)分,低于对照组的(52.56±6.26)mL、(51.06±6.35)分,Qmax指标为(18.41±2.12)mL/L,高于对照组的(10.62±1.15)mL/L,差异有统计学意义(t=4.402、4.221、13.797,P<0.05)。观察组治疗有效率(100.00%)高于对照组(70.59%),且并发症发生率(4.00%)低于对照组(35.29%),差异有统计学意义(χ^(2)=5.778、5.060,P<0.05)。结论予以高危、超大前列腺增生患者经尿道前列腺等离子剜除术联合耻骨上小切口治疗疗效确切,安全性高。
Objective To analyze the clinical effect of transurethral plasma enucleation of prostate combined with small suprapubic incision in patients with high-risk and super large benign prostatic hyperplasia.Methods 42 patients with high-risk and super large benign pro static hyperplasia treated in Xinyi Hospital of Traditional Chinese Medicine from January 2018 to December 2021 were selected as the research objects.The 42 patients were divided into two groups by random number table method.17 cases treated by transurethral resection of prostate were included in the control group,25 cases treated by transurethral plasma enucleation of prostate combined with small suprapubic incision were included in the observation group.The clinical effects of the two groups were compared.Results The amount of intraoperative bleeding in the observation group was(52.19±6.25)mL,which was less than(65.76±8.45)mL in the control group.The time of operation and bladder flushing was(62.20±10.45)min,(5.20±1.10)min,which was shorter than(75.52±9.48)min,(7.70±1.54)min in the control group.The weight of tissue removed during operation was(97.57±8.25)g,which was greater than(86.26±8.32)g in the control group,the difference was statistically significant(t=5.986,4.206,6.145,4.339,P<0.05).The RUV index and IPSS score of the observation group were(43.20±7.08)mL,(42.28±6.78)points,lower than that of the control group(52.56±6.26)mL,(51.06±6.35)points.Qmax index was(18.41±2.12)mL/L,higher than that of the control group(10.62±1.15)mL/L,the difference was statistically significant(t=4.402,4.221,13.797,P<0.05).The effective rate of the observation group(100.00%)was higher than that of the control group(70.59%),and the incidence of complications(4.00%)was lower than that of the control group(35.29%),the difference was statistically significant(χ^(2)==5.778,5.060,P<0.05).Conclusion Transurethral plasma enucleation of prostate combined with suprapubic small incision is effective and safe in patients with high-risk and super large benign pro static hyperplasia.
作者
刘兵
LIU Bing(Department of Urology,Xinyi Hospital of Traditional Chinese Medicine,Xinyi,Jiangsu Province,221400 China)
出处
《系统医学》
2022年第13期142-145,共4页
Systems Medicine
关键词
高危前列腺增生
超大前列腺增生
经尿道前列腺等离子剜除术
耻骨小切口
High risk prostatic hyperplasia
Large benign prostatic hyperplasia
Transurethral plasma enucleation of prostate
Pubic small incision
